Scienture Holdings, Inc. (SCNX)
Develops experimental medicines for high blood pressure, migraines, blood clots, and post-surgery pain.
$0.38+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-80.4%
The outlook
SCNX trades at $0.375, well below both its 50- and 200-day moving averages and near its 52-week low. Analyst coverage leans bearish overall, though the average price target sits roughly 300% above the current price. The stock remains highly speculative with minimal upward momentum in its recent trend.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +300% vs current price
Market cap
$15.2M
52-wk high
$2.60
52-wk low
$0.24
50-day avg
$0.38
200-day avg
$0.49
Trailing P/E
—